title: Lymphangitis and refractory lymphedema after treatment with topical cantharidin.
authors.forename: A M
authors.initials: AM
authors.lastname: Stazzone
authors.forename: P
authors.initials: P
authors.lastname: Borgs
authors.forename: C L
authors.initials: CL
authors.lastname: Witte
authors.forename: M H
authors.initials: MH
authors.lastname: Witte
mesh_terms: D000279:Administration, Cutaneous; D000328:Adult; D002193:Cantharidin / Q000009:adverse effects*; D002481:Cellulitis / Q000139:chemically induced; D005260:Female; D005534:Foot Diseases / Q000188:drug therapy; D006801:Humans; D007509:Irritants / Q000009:adverse effects*; D008205:Lymphangitis / Q000139:chemically induced* / Q000000981:diagnostic imaging; D008209:Lymphedema / Q000139:chemically induced* / Q000000981:diagnostic imaging; D011877:Radionuclide Imaging; D019275:Radiopharmaceuticals; D013668:Technetium Tc 99m Aggregated Albumin; D014860:Warts / Q000188:drug therapy
chemical_list: D007509:Irritants; D019275:Radiopharmaceuticals; D013668:Technetium Tc 99m Aggregated Albumin; D002193:Cantharidin